Go Ad-Free
My Alerts
Moneycontrol
Moneycontrol PRO
Get App Open
In App
News on WhatsApp
News on WhatsApp
Go PRO Now
Open App
Success
Alert
Please select a Day.
Info

Beryl Drugs Ltd.

Sector : Healthcare | Industry : Pharmaceuticals & Drugs
xpert
Have a query? Talk to Experts LIVE
Add to

54/100
23.25
-0.63 (-2.64%)

As on 02 Jan, 2026 | 04:01

Day Range
22.25
23.90
L H
52 Week Range
17.35
43.00
L H
Volume
942
*
i

* BSE Market Depth (02 Jan 2026)

BUY SELL
QTY PRICE PRICE QTY
170 22.53 23.25 52
50 22.52 23.49 50
120 22.51 23.75 248
1000 22.50 24.00 50
51 22.25 24.25 358
0 Total Total 0
Bid / Ask
0.00 / 0.00
Compare Stocks Advanced Chart
NSE
MC Essentials
59% Pass
MC Technicals
i
This represents current trend.Click here for disclaimer.
MC Insights

Superior Financial Strength, Low Growth Trend Stock at Reasonable Valuations

Financials
    Ownerships
      Industry Comparison
        Others
          Open 0.00
          Previous Close 0.00
          Volume 0.00
          Value (Lacs) 0.00
          VWAP 0.00
          Beta
          Mkt Cap (Rs. Cr.) 0
          High 0.00
          Low 0.00
          UC Limit 0.00
          LC Limit 0.00
          52 Week High 0.00
          52 Week Low 0.00
          Face Value 0.00
          All Time High 0.00
          All Time Low 0.00
          20D Avg Volume 0
          20D Avg Delivery(%) --
          Book Value Per Share --
          Dividend Yield --
          TTM EPS See historical trend 0.00
          TTM PE See historical trend --
          P/B See historical trend --
          Sector PE 0.00

          Advanced Chart

          Click here to expand
          xpert

          *Delayed by 20 seconds.

          Forecast                                                

          Earnings Forecast

          Actuals Estimates
          ANNUALLY 
          (Rs.) 

          Valuations

          Consensus Recommendations

          • Buy
          • Outperform
          • Hold
          • Underperform
          • Sell

          Hits/Misses

          QUARTERLY (Rs.)
          # of Beats
          # of Misses
          # of Inline
          # of Beats
          # of Misses
          # of Inline
          # of Beats
          # of Misses
          # of Inline

          MC Insights

          Stock Score

          54/100
          Superior Financial Strength, Low Growth Trend Stock at Reasonable Valuations

          Get detailed analysis with Moneycontrol Stock Insights.

          Get detailed analysis with Moneycontrol Stock Insights.

          Price
          • 45.93% away from 52 week high

          Financials
          Piotroski Score
          i

          indicates

          Industry Comparison
          • Market Cap - Below Median

          Shareholding Pattern
          • Promoter holding remains unchanged at 26.38% in Sep 2025 qtr.

          MC Technicals

          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          See Detail
          ` Historical Rating
          Moving Averages --
          Technical Indicators --
          Moving Averages Crossovers --

          Pivot levels

          Type R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

          Pivot levels

          R1 - - Pivot
          - -          		 S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

          Moving Averages
          Days
          5 - -
          10 - -
          20 - -
          50 - -
          100 - -
          200 - -
          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          See Detail
          Historical Rating
          Moving Averages --
          Technical Indicators --
          Moving Averages Crossovers --

          Pivot levels

          Type R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

          Pivot levels

          R1 - - Pivot
          - -          		 S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

          Moving Averages
          Days
          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          See Detail
          Historical Rating
          Moving Averages --
          Technical Indicators --
          Moving Averages Crossovers --

          Pivot levels

          Type R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

          Pivot levels

          R1 - - Pivot
          - -          		 S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

          Moving Averages
          Days

          Price and Volume

          Price Performance
          1 Week
          		--%
          1 Month
          		--%
          3 Months
          		--%
          YTD
          		--%
          1 Year
          		--%
          3 Years
          		--%
          Volume Analysis
          • Volume
          • Delivery

          SEASONALITY ANALYSIS

          8 out of 17 years Beryl Drugs has given negative returns in January.

          Month Max. Positive Change(%) Avg. Positive Change(%) Max. Negative Change(%) Avg. Negative Change(%) Average Change(%)
          January 52.01% (2024) 21.31% -14.29% (2013) -3.94% 8.68%
          Seasonality Analysis

          Forum

          Community Sentiments

          • 0% BUY
          • 100% SELL
          • 0% HOLD
          100%
          of moneycontrol users recommend selling Beryl Drugs

          What's your call on Beryl Drugs today?

          Read 0 investor views

          BUY SELL HOLD
          POST

          Broker Research

          No Data For Broker Research.

          Deals

          No Data For Block Deals.

          *Transaction of a minimum quantity of 500,000 shares or a minimum value of Rs 5 crore.

          16 Dec, 2025

          Pradeep Kumar Jain

          Qty 100000 Price 22.5 % Traded 2.02
          16 Dec, 2025

          Samir Narendra Gupta

          Qty 99921 Price 22.5 % Traded 2.02
          28 Feb, 2025

          Samir Narendra Gupta

          Qty 100001 Price 24.85 % Traded 2.00
          28 Feb, 2025

          Narendrakumar Bhagwandas Gupta

          Qty 100000 Price 24.85 % Traded 2.00
          09 Sep, 2024

          Narendrakumar Bhagwandas Gupta

          Qty 38038 Price 43.23 % Traded 0.73
          06 Sep, 2024

          Narendrakumar Bhagwandas Gupta

          Qty 74475 Price 38.6 % Traded 1.47

          *A bulk deal is a trade where total quantity of shares bought or sold is more than 0.5% of the equity shares of a company listed on the exchange.

          Financials

          (Rs. Cr)
          • Revenue
          • Net Profit
          • EPS
          • BVPS
          • ROE
          • Debt to Equity

          Detailed Financials

          (Rs. Cr)
          • Revenue
          • Net Profit
          • EPS
          • BVPS
          • ROE
          • Debt to Equity

          Detailed Financials

          Shareholding

          Summary
          See Top Holdings
          Trend

          About the Company

          Beryl Drugs Ltd is into manufacturing and marketing of branded, generic pharmaceutical formulations. The company is one of the leading manufacturer of I.V.fluids and small volume injectables.They own brands like BERI-CEF injection, F-Neuron, Amplicillin INJ, P-Mol, Biprox, B-Flox and many more.Products manufactured by the company include Small volume injectables in liquid form,Small volume injectables in dry powder form, Variety of eye and ear drops,I.V.Fluids in polypack and glass bottles and Variety of vetrinary medicines
          {"success":1,"data":{"address":{"address1":"133, Kanchan Bagh,","address2":",","city":"Indore","state":"Madhya Pradesh","pincode":"452001","telephone1":"0731-2517677","telephone2":"","fax1":"0731-25065375","fax2":"0731-3046366","email":"beryldrugs25@yahoo.com","web":"http:\/\/www.beryldrugs.com"},"management":[{"name":"Sudhir Sethi","designation":"Chairman & Director"},{"name":"Sanjay Sethi","designation":"Managing Director"},{"name":"Abhinav Naik","designation":"Independent Director"},{"name":"Shreya Saraf","designation":"Independent Woman Director"}],"registrars":{"name":"Adroit Corporate Service (P) Ltd.","address1":"No.19\/20, Jafferbhoy Industrial Estate, \n1st Floor","address2":"","address3":"","address4":"","telephone":"022-42270400, 28596060, 28594060","fax":"022-28503748, 66924438","email":"info@adroitcorporate.com","internet":"http:\/\/www.adroitcorporate.com","city":"Mumbai","state":"Maharashtra","pincode":"400059"},"listing":[{"name":"BSE 100","value":"No"},{"name":"BSE 200","value":"No"},{"name":"SENSEX","value":"No"},{"name":"CNX MIDCAP 200","value":"No"},{"name":"NIFTY 50","value":"No"},{"name":"BSE 500","value":"No"},{"name":"Nifty 200","value":"No"}],"details":{"bseId":"524606","nseId":"","series":"","isinid":"INE415H01017"}}}

          • Registered Office

          • Registrars

          • Management

            • Sudhir Sethi

              Chairman & Director

            • Sanjay Sethi

              Managing Director

            • Abhinav Naik

              Independent Director

            • Shreya Saraf

              Independent Woman Director

            + See More

          • Included In

            • BSE 100

              No

            • BSE 200

              No

            • SENSEX

              No

            • CNX MIDCAP 200

              No

            • NIFTY 50

              No

            • BSE 500

              No

            • Nifty 200

              No

          • Details

            • BSE:

              524606

            • NSE:

            • Series

            • ISIN

              INE415H01017

          Go to Top
          Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347